The Peripheral Intravenous Catheters (PIVC) market size was valued at USD 3.76 Billion in 2022 and is projected to reach USD 6.72 Billion by 2030, growing at a CAGR of 7.5% from 2024 to 2030. This growth is driven by an increasing demand for intravenous procedures, rising incidences of chronic diseases, and a greater focus on patient safety and comfort. The growing healthcare infrastructure in emerging markets and advancements in catheter technology are also contributing to the market's expansion. PIVCs are essential for the administration of fluids, medications, and nutrients, which makes them critical in both inpatient and outpatient care settings. The increasing number of surgical procedures and the rising prevalence of conditions requiring intravenous access, such as diabetes, cancer, and kidney diseases, are further accelerating market growth. Additionally, rising healthcare expenditure, an aging population, and improved healthcare access are expected to fuel demand for peripheral intravenous catheters globally. North America and Europe currently dominate the market, but the Asia Pacific region is anticipated to witness the highest growth rate during the forecast period due to the rapid development of healthcare infrastructure in the region.
Download Full PDF Sample Copy of Market Report @
Peripheral Intravenous Catheters PIVC Market Research Sample Report
The Peripheral Intravenous Catheters (PIVC) market is primarily driven by the diverse applications across various healthcare settings. The demand for PIVCs is heavily influenced by the growing need for efficient and safe venous access for fluid administration, medication delivery, and diagnostic sampling. The market is segmented by application into hospitals, clinics, ambulatory surgical centers (ASCs), and other healthcare facilities. Each segment has its unique requirements and characteristics that impact the PIVC market dynamics. The usage of PIVCs is widespread, and their role is crucial in both routine medical procedures and emergency situations, which significantly contributes to market growth.
Hospitals remain the largest application segment in the PIVC market, owing to their vast infrastructure and patient volume. They cater to a wide range of medical procedures requiring intravenous therapy, such as chemotherapy, fluid and electrolyte management, and pain management. The demand for PIVCs in hospitals is also driven by their use in emergency departments, intensive care units (ICUs), and neonatal units, where rapid and reliable venous access is essential. In hospital settings, the need for high-quality, sterile, and durable PIVCs is paramount, as they help reduce the risk of complications like infection or phlebitis, ensuring better patient outcomes. The increasing number of patients with chronic conditions, such as diabetes and cardiovascular diseases, further boosts the hospital segment, which requires long-term intravenous treatments.
In addition, the growing trend towards hospital automation and the integration of smart technologies also contributes to the evolving needs of PIVCs in hospitals. Innovative catheter designs that reduce complications and enhance patient comfort are gaining prominence. Hospitals are increasingly focusing on improving patient safety, leading to an emphasis on PIVCs that feature advanced materials and technologies to minimize the risk of catheter-related infections and mechanical failure. As a result, hospitals represent a significant portion of the market share and are expected to maintain dominance in the foreseeable future.
Clinics, especially outpatient care centers, represent an expanding segment within the PIVC market. With the rise in the number of outpatient procedures, PIVCs are becoming essential for administering treatments like intravenous medication, hydration therapy, and diagnostic tests. Clinics cater to a growing patient population seeking non-urgent medical services, and the demand for efficient and reliable intravenous access solutions has escalated accordingly. In this setting, PIVCs are generally used for short-term procedures and interventions, where ease of insertion and patient comfort are key considerations.
The clinic segment is also influenced by the increasing focus on reducing healthcare costs and enhancing operational efficiency. Clinics typically serve a large number of patients with various needs, requiring a steady supply of PIVCs for a wide range of diagnostic and therapeutic applications. Furthermore, as healthcare systems worldwide focus on enhancing outpatient care capabilities, the clinic segment is poised for continued growth. Clinics are increasingly adopting high-performance PIVCs that offer faster insertion times, lower complication rates, and better patient experiences, aligning with the trend toward improving overall healthcare quality in outpatient settings.
Ambulatory Surgical Centers (ASCs) have emerged as a rapidly growing segment in the PIVC market due to their focus on outpatient surgical procedures that require intravenous access for anesthesia, medication delivery, and post-operative care. ASCs typically handle a wide range of elective and minimally invasive surgeries, including orthopedic, gastrointestinal, and ophthalmic procedures. The need for reliable, low-complication PIVCs in these settings is critical, as they help ensure the smooth administration of fluids and drugs during surgeries and recovery periods. ASCs typically cater to lower-risk patients and are a more cost-effective option compared to hospitals, further driving their preference for PIVCs in outpatient surgery.
In addition to their role in routine surgeries, ASCs are increasingly adopting advanced catheter technologies that offer enhanced features such as improved patient comfort and reduced infection risk. The increasing shift towards outpatient surgical procedures, as a result of rising healthcare costs and patient preference for less invasive options, is expected to further fuel the demand for PIVCs. The market for PIVCs in ASCs is likely to expand as these centers continue to grow in both size and number, positioning this segment as a key contributor to the overall PIVC market growth.
The "Other" segment includes a variety of healthcare facilities such as nursing homes, home healthcare settings, and urgent care centers, which are increasingly relying on PIVCs to provide intravenous therapy and care for their patients. The growing demand for home healthcare, particularly for elderly and chronically ill patients who require long-term intravenous treatments, has contributed to the expansion of PIVC applications in these settings. As these facilities generally cater to patients with lower acuity compared to hospitals, the usage of PIVCs tends to be more focused on long-term therapies, such as antibiotic infusions, hydration treatments, or nutritional support.
The "Other" segment is also witnessing an increase in the use of advanced, patient-friendly PIVCs designed for home use. These innovations allow for greater mobility and comfort, which is particularly important for patients in non-hospital settings. Furthermore, the increasing preference for non-institutionalized care and the expansion of healthcare services to rural areas and communities are expected to continue driving the demand for PIVCs in these alternative healthcare facilities. This growth in home and nursing care is a significant trend that enhances the market potential for PIVCs beyond traditional healthcare environments.
The PIVC market is experiencing several key trends and opportunities that will shape its future trajectory. One of the most significant trends is the increasing adoption of advanced technologies in catheter design, which focuses on reducing complications such as infection and phlebitis, enhancing patient comfort, and improving the ease of insertion. Innovations such as antimicrobial-coated PIVCs, needle-free systems, and smart catheters that track insertion depth and placement are gaining popularity across hospitals, clinics, and ASCs.
Another notable trend is the rising demand for home healthcare solutions, which is driving the development of user-friendly PIVCs suitable for long-term intravenous therapies in non-hospital settings. The global shift towards outpatient care and the increasing prevalence of chronic diseases such as diabetes and cancer also present opportunities for growth in the PIVC market. Additionally, as healthcare systems strive to reduce costs and improve patient outcomes, there is an increasing emphasis on PIVCs that offer higher reliability, faster insertion, and fewer complications, creating significant opportunities for manufacturers and healthcare providers.
What are Peripheral Intravenous Catheters (PIVCs)?
Peripheral Intravenous Catheters (PIVCs) are devices used to provide venous access for fluid and medication administration, commonly used in hospitals, clinics, and other healthcare settings.
Why are PIVCs important in healthcare?
PIVCs are critical for safe and efficient intravenous access, enabling the delivery of fluids, medications, and nutrients to patients who require them for medical treatments.
What are the key advantages of PIVCs?
The main advantages of PIVCs include ease of insertion, low cost, and their ability to provide temporary venous access for a variety of treatments and diagnostic procedures.
How do PIVCs differ from central venous catheters?
PIVCs are inserted into smaller peripheral veins and are typically used for short-term access, while central venous catheters are inserted into larger veins for long-term or more intensive treatments.
What are the common complications associated with PIVCs?
Common complications include infection, phlebitis, occlusion, and infiltration. Proper insertion techniques and care can minimize these risks.
What innovations are driving the PIVC market?
Innovations such as antimicrobial coatings, smart catheters, and needle-free systems are improving the functionality and safety of PIVCs, boosting their adoption across healthcare settings.
What is the expected growth rate of the PIVC market?
The PIVC market is expected to grow steadily, driven by the increasing demand for outpatient care, chronic disease management, and advancements in catheter technologies.
Why are PIVCs used in ambulatory surgical centers (ASCs)?
PIVCs are used in ASCs to administer anesthesia, fluids, medications, and to monitor patients during and after surgical procedures, ensuring a safe recovery.
How do home healthcare services utilize PIVCs?
Home healthcare services use PIVCs for patients requiring long-term intravenous therapy, such as antibiotic infusions, hydration, and nutritional support.
What factors are influencing the growth of the PIVC market?
Factors such as the growing demand for outpatient services, technological innovations in catheter design, and the shift towards home healthcare are fueling the growth of the PIVC market.
For More Information or Query, Visit @ Peripheral Intravenous Catheters PIVC Market Size And Forecast 2025-2030
Â